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T here exists a dire need to raise and standardize the quality of healthcare delivery in many disease conditions, including obstructive sleep apnea (OSA). 1 Unique to OSA are the uncertainties of disease definition, 2 large variability in scoring of polysomnograms and therefore diagnosing OSA, 3, 4 and also multidisciplinary backgrounds and respective biases of physicians who treat OSA. 5 In light of such variability, the training for physicians offered by formal sleep-medicine fellowships, and the benchmarks advocated by the American Academy of Sleep Medicine (AASM) for the workings of a sleep center, afford greater conformity and set standards of practice for individual physicians and sleep centers. 6 So far, a systematic assessment of the effect of AASM center accreditation and sleep-medicine certification of physicians on clinical outcomes in patients with OSA has not been reported. In order to measure the effect of AASM accreditation and sleep-medicine certification on clinical outcomes in patients with OSA, several important endpoints can be considered.
One such endpoint that poses a challenge in the management of patients with OSA is patient adherence to positive airway pressure (PAP) therapy. 7 While the minimum required adherence-in hours of PAP therapy used per night-is unclear, 8 discontinuation of PAP device is an unambiguous endpoint for treatment failure. In this study, we used such a clear definition of treatment failure-proportion of patients who discontinued PAP therapy-to measure the performance of physicians and sleep centers. Additionally, because patients' risk perceptions of OSA and their knowledge of their disease condition are important to ensure adherence to therapy, 8, 9 we assessed patients' perceptions of whether such information was dispensed by their physicians or sleep centers. Lastly, other important benchmarks in the management of patients with OSA, such as timely delivery of care 10 (time lapse between initial sleep study and institution of PAP therapy) and patients' overall satisfaction with care rendered by their physicians and centers, were also assessed.
We designed a survey that asked patients about the care they received from their physicians and sleep centers for their OSA condition. The overall purpose of the study was to study the effect of AASM accreditation of sleep centers and sleep-medicine certification of physicians on the clinical management of patients with OSA through a web-based survey. We hypothesized that patients with OSA who are cared for by sleep-certified physicians or AASM-accredited centers are less likely to discontinue PAP therapy than are patients cared for by noncertified physicians and nonaccredited centers. We also hypothesized that patient education regarding OSA and associated risks are provided by a greater proportion of sleep-certified physicians and AASM-accredited centers than by noncertified physicians and nonaccredited centers. Lastly, we hypothesized that sleep-certified physicians and AASM-accredited centers provide more timely care and achieve greater patient-satisfaction ratings than do noncertified physicians and nonaccredited centers.
METHODS

Patients
We conducted a cross-sectional study of 632 patients with OSA across the country using a web-based survey. Of the 842 "hits" to the web site containing the questionnaire, 632 patients took the time to respond to the questionnaire. Patients were naïve to the exact purposes of the study. Patients older than 20 years of age with a diagnosis of OSA were solicited to take the anonymous web-based survey (see Appendix). Such solicitations to participate were placed on web sites frequented by patients with OSA: sleep apnea support groups (American Sleep Apnea Association, Washington, DC), other educational web sites (such as apneanet.org, Glen Ellyn, IL), vendors of PAP therapy devices (such as cpapstore.com, Kennewick, Wash, and cpaptalk. com, Missouri City, TX), and Internet chat groups (such as the one sponsored by the AASM, sleepeducation.com, Westchester, IL). The Institutional Review Board of the University of Arizona approved the study and waived the need for documentation of written informed consent.
Questionnaire Tool
Patients were asked to respond yes, no, or don't know to the following questions: (1) whether the physician managing their sleep-apnea condition is a sleep expert (an Internet link to the AASM web site with a state-wise list of certified sleep physicians was provided); (2) whether the sleep center that they received service from was accredited (an Internet link to the AASM web site with state-wise list of AASM-accredited centers was provided); (3) whether they received adequate education from the healthcare provider in any form-verbal, audiovisual, or pamphlets; (4) whether such education improved their understanding of their disease condition; (5) whether such education helped them realize the risks associated with OSA; and (6) whether they were satisfied with their physician's management of their sleep-apnea condition on a 5-point Likert scale that ranged from very dissatisfied (score of 1) to very satisfied (score of 5).
11 Also, they were asked to evaluate the sleep center on a 5-point satisfaction scale. 11 Patients were asked whether they were continuing to use the PAP device or whether they had stopped using such therapy. Patients were also asked to report when they received their PAP device in relation to their first sleep study and the duration of time that they have had the PAP device.
Potential confounders that may affect acceptance of PAP device were also measured: PAP pressure level, device type (automatic PAP, bilevel PAP, or continuous PAP), presence and severity of nasal congestion, age, sex, height, weight (for calculations of body mass index), and highest education (did not finish high school, finished high school, college, masters, or doctorate). Potential confounders for timeliness in healthcare delivery such as type of health insurance (HMO, PPO, POS, Medicare, or lack of any insurance) were also requested. Also, subjective improvement in sleepiness after the initiation of PAP therapy was measured using a 5-point Likert scale, 12 and self-reported hours of PAP-device use was sought. Patient responses were saved in the file server and analyzed in aggregate.
Questionnaire Validation
We measured nasal congestion using a 5-point Likert scale that was previously administered to patients with sleep-disordered breathing.
13 Nasal-congestion severity was scored in the following manner: 0 for never congested, 1 for rarely, 2 for sometimes, 3 for most of the time, and 4 for always. Additionally, we revalidated this 5-point Likert scale against a well-validated nasal symptom scale.
14, 15 We performed such validation in a separate cohort of 54 patients with OSA by correlating nasal-congestion scores obtained by our single question versus the previously wellvalidated, multiple-question nasal symptom scale. There was good consistency between the 2 measures (Cronbach α coefficient of 0.79).
Initial construction of questions relating to patient satisfaction was based on patient interviews. Subsequently, an initial data set of 50 patient responses and input from sleep-medicine experts was used to identify questions that made the largest contribution to variation in satisfaction scores and to shorten and edit the questionnaire. Internal consistency for the patient educationrelated questions was excellent (Cronbach α coefficient of 0.93; questions 3, 4, and 5 in Appendix) and good for patientsatisfaction questions (Cronbach α coefficient of 0.75; questions 7 and 8 in Appendix).
Data Analysis
ENDPOINTS
The primary endpoint for analysis was discontinuation of PAP therapy. Secondary endpoints were (1) patients' perceptions of education they received regarding OSA and risks associated with OSA, (2) time delay in instituting PAP therapy, and (3) overall patient satisfaction of the care delivered by the physician and center, measured separately.
PREDICTORS AND COVARIATES
In order to assess the combined "dose-effect" of sleep certification of physicians and AASM accreditation of the centers on patient outcomes, we assigned patients to 1 of 3 groups: (1) the physician was certified and the center was accredited, (2) either the physician was certified or the center was accredited, and (3) neither was the physician certified nor was the center accredited. From the list of predictors and potential confounders, simple logistic-regression analysis was performed to identify significant covariates that influenced discontinuation of PAP therapy. Subsequently, we built multivariate logistic-regression models with continued use of PAP device as the dependent variable using significant covariates identified by simple logistic-regression analysis (p < .05).
Also, general linear models were constructed to identify determinants of timely delivery of care and self-reported adherence to PAP therapy (expressed as hours per week). Multicollinearity among independent variables was verified, and, in the event of collinearity, the strongest predictor variable alone was included. Nonparametrically distributed variables-such as time delaywere log transformed to meet assumptions of normality required for multiple regression. All analyses used a list-wise deletion strategy for missing values. Results are presented as mean and standard deviation unless otherwise specified. All tests for significance and resulting p values were 2-sided, with a significance level of .05. All analyses were performed using SPSS v12.0 (SPSS Inc., Chicago, IL). Unadjusted proportions were compared using Pearson χ 2 test with Bonferroni correction applied when appropriate.
POWER ANALYSIS
Acceptance of PAP-device therapy has been reported to range from 75% to 80% of patients who were prescribed such therapy. 16, 17 We assumed a PAP-acceptance proportion of 70% in patients cared for by nonaccredited centers or physicians and 80% in the AASM-accredited centers or physicians-a difference of 10%. Based upon such assumptions, we estimated that we would need 412 patients per group-a total of 824 responses (assuming also that α is .05, 2-sided, power of 90% using χ 2 ). We report significant results from the planned midpoint interim analysis-444 responses with accreditation or certification status.
RESULTS
Description of Respondents
Of the 842 "hits" to the web site containing the questionnaire, 632 responded to the survey (overall response rate of 75%). The mean age of patients was 51 ± 10 years (range from 20-89 years) with 35% comprising women. Average body mass index was 35.7 ± 8.9 kg/m 2 , and average continuous PAP pressure was 11.5 ± 3.6 cm h 2 o, with 78% of patients having been prescribed continuous PAP devices. A minority of patients were prescribed automatic PAP (10%) and bilevel PAP devices (12%). Of the 632 responses, 444 patients had responded as knowing both their physician's certification status and their sleep center's accreditation status, while 188 patients were unaware of the accreditation status of their physician, the certification status of their sleep center, or both.
Discontinuation of PAP Therapy and Adherence
Of the 444 patients who identified physician-accreditation status and center-certification status, 16 (5%) of 307 patients who were cared for by certified physicians and accredited centers had stopped using their PAP devices. In contrast, 7 (7%) of 99 patients cared for by either certified physicians or accredited centers had stopped using their PAP devices, and 8 (21%) of 38 patients who were cared for by noncertified physicians and nonaccredited centers had stopped using their PAP device (χ 2 ; p = .001)( Table  1) . Besides accreditation or certification status, Table 2 shows the relationship between other significant covariates (derived from Table 1 ) and discontinuation of PAP therapy. The odds ratios are hazard ratios for discontinuation of PAP therapy (Table 2) . From Table 2 , covariates were entered into a forward-regression model (Table 3) . Block 1 consisted of covariates that are known to influence acceptance of PAP therapy (age, body mass index, and health insurance), block 2 consisted of covariates of interest (nasal-congestion score and medications for nasal congestion), and block 3 consisted of predictors (lack of accreditation or certification status or risk perception due to patient education).
Multivariate logistic-regression analysis (Table 3) revealed that lack of accreditation of physician or certification of center and severity of nasal congestion score were independently associated with discontinuation of PAP therapy (Table 3 ). In contrast, patient education leading to enhanced perception of risk associated with OSA, having health insurance, and medications for nasal congestion "protected" against discontinuation of PAP therapy (Table 3) . If both risk perception and lack of accreditation or certification 135 AASM and OSA Management Data are presented as number (percentage). Pearson χ 2 test for association (p = .001) PAP refers to positive airway pressure; Both, both the physician was certified and the center was accredited; One, either the physician was certified or the center was accredited; None, neither the physician was certified nor was the center accredited; n= number of patients. Table  3 ), accreditation or certification status was no longer significant (B = -0.46; SE = 0.30; p = .12). This is likely due to significant collinearity between these 2 variables (r = -0.27, p < .001). These findings suggest that risk perception and education may mediate the relationship between accreditation or certification status and PAP discontinuation. Self-reported usage of PAP device was higher for patients cared for by accredited versus nonaccredited centers: 44.2 ± 14.4 versus 39.6 ± 19.8 hours per week, respectively (p = .017). Similarly, patients cared for by certified physicians tended to use their PAP device for longer durations than did patients cared for by noncertified physicians: 44.3 ± 14.4 versus 41.3 ± 18.6 hours per week, (Table  3) . While the combined "dose-effect" of certification or accreditation status, risk perception, prescription of nasal medications, and body mass index were directly related to self-reported adherence to PAP therapy, nasal congestion score was inversely related to self-reported adherence to PAP therapy (p < .05).
Degree of improvement in subjective sleepiness was measured by a 5-point Likert scale that ranged from -1 (sleepiness is worse), 0 (no change), +1 (slightly improved), +2 (substantially improved), and +3 (completely resolved). As expected, the Likert scores for improvement in sleepiness were greater in patients who were continuing to use PAP therapy (1.76 ± 0.78) than in patients who had discontinued such therapy (0.53 ± 1.23; p < .0001)(question 27; Appendix). Moreover, the degree of improvement in sleepiness was directly correlated with the hours of self-reported adherence to PAP therapy (R = 0.44; p < .0001).
Patient Education
Certified physicians and accredited centers were more likely to provide adequate education to patients regarding OSA. Physician certification and center accreditation were associated with a greater proportion of patients receiving adequate education regarding OSA (Table 4) . Seventy-seven percent of patients cared for by certified physicians and accredited centers reported receiving adequate education regarding OSA. In contrast, only 43% of patients cared for by noncertified physicians and nonaccredited centers reported receiving adequate education regarding OSA (p < .0001; Table 4 ). Similarly, the accreditation status of the caring physician and the certification status of the center were also directly related to the proportion of patients who received education that led them to perceive the risks associated with OSA (Table  4) . Patients who were cared for by noncertified physicians and nonaccredited centers were more likely to seek information regarding OSA elsewhere than were those patients who were cared for by certified physicians and accredited centers (Table 4) . Similar findings were noted when such educational endpoints were 136 S Parthasarathy, PL Haynes, R Budhiraja et al Risk perception and lack of accreditation or certification were collinear; therefore they are inserted separately. analyzed after patients were grouped by physician-certification or center-accreditation status alone ( Table 4) .
Timeliness of Care
Timeliness of care-time delay between the first sleep study and when the patient received the PAP device-was a median of 27 days (interquartile range; 7 to 30). Timeliness of care was not related to physician-certification or center-accreditation status, either individually or when considered together (P>.2). Timeliness of care was inversely related to the duration of therapy (R= -0.22; p < .0001; Figure 1) . Notably, the insurance status (insured versus not), type of insurance carrier, and issuance of an automatic PAP device were not associated with speedier service (p > .4).
Patient Satisfaction
Patient-satisfaction scores for care rendered by the physicianwith a highest score of 5 signifying greatest satisfaction-was higher in patients cared for by certified physicians (3.78 ± 1.18) than noncertified physicians (3.19 ± 1.27; p < .0001). After univariate regressions identified significant explanatory variables, general linear models revealed that the following were independently associated with lower patient-satisfaction scores: not perceiving the risk of OSA through education received, discontinuation of PAP therapy, noncertified physicians, and longer time delays (log of time delay) in instituting PAP therapy (Table 5) .
Patient-satisfaction scores for care rendered by the centerwith a score closer to 5 signifying greater satisfaction-was higher in patients cared for by accredited centers (4.11 ± 0.98) than those cared for by nonaccredited centers (3.58 ± 1.24; p < .0001). After univariate regressions identified significant explanatory variables, general linear models revealed that the following were independently associated with lower patient-satisfaction scores: time delays in instituting PAP therapy (log of time delay), nonaccredited centers, not perceiving the risk of OSA through education received, and discontinuation of PAP therapy (Table 5) .
Internal and External Validity
Besides the good-to-excellent internal consistency between components of the questionnaire (Cronbach α coefficient of 0.75 to 0.93; Methods section), we further checked the data for internal and external validity. First, for external validity, the demographics of our patient population (age, height, weight, and sex) and continuous PAP pressure level are very similar to those reported in other large series of patients with OSA. [18] [19] [20] [21] Moreover, the proportion of patients who received continuous, automatic, and bilevel PAP devices-78%, 10%, and 12%-is similar to prior reports 22 (external validity). In order to further assess the internal validity, we correlated self-reported pressure level of the continuous PAP therapy versus self-reported body mass index. In our study, selfreported pressure level prescribed for continuous PAP therapy was positively correlated with body mass index (R = 0.41; p < .0001).
DISCUSSION
To our knowledge, this is the first study to show an effect of physician sleep certification and sleep center accreditation on discontinuation of PAP therapy and self-reported adherence to PAP therapy in patients with OSA. Moreover, in comparison with patients cared for by nonaccredited centers and noncertified physicians, patients cared for by accredited centers and certified physicians were more likely to have perceived the risks of OSA through education and were more satisfied with their care. Time delays in instituting therapy for patients with OSA were not influenced by accreditation-certification status of physicians and centers but unfavorably impacted patient satisfaction. In patients with OSA, worsening nasal congestion and lack of medications for nasal congestion are independent risk factors for discontinuing PAP therapy and low hours of device use. 
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Risk Perception and Education
Reports cite that between 25% and 50% of patients with OSA may abandon treatment during the first 2 to 4 weeks of treatment. [23] [24] [25] [26] Although physical factors such as poor mask fit, nasal congestion, and high pressure contribute to such nonadherence, psychological factors may play a major role as well. 7, 9 Using the social cognitive model, 27 Weaver and colleagues developed a questionnaire-based instrument involving 3 major cognitions that play a role in adherence to PAP therapy-patient's perception of health risk associated with OSA, patient's expectations of outcomes, and patient's perceived ability to use the PAP device. 7 In this instrument, perception of risk was an additional, and important component, believed to determine and predict patient behavior in response to therapy and considered an improvement over a prior model. 9 Such perception of risk is usually imparted by educating the patient regarding disease-specific outcomes and health risks. 27, 28 In our study, education leading to a patient's perception of risk due to OSA was associated with decreased odds for discontinuing PAP therapy (adjusted odds ratio [OR] 0.5, p = .03; step 3, Table 3 ). This is in agreement with other investigations showing the beneficial effect of intensive education on adherence to PAP therapy.
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Certification-Accreditation Status
In our study, successful education of the patient regarding the health risks of OSA was performed more often by certified physicians and accredited centers than by noncertified physicians and nonaccredited centers (Table 4) . Such education leading to risk perception may underlie the lower likelihood for discontinuation of PAP therapy in patients cared for by certified physicians and accredited centers than in patients cared for by noncertified physicians and nonaccredited centers. This is further supported by the collinearity between "risk perception" and accreditation or certification status in our regression model (Table 3) . Besides promoting adherence to PAP therapy through education, physicians may favorably influence adherence to PAP therapy by other means: prescription of medications to relieve nasal congestion, heated humidifier, 30 or choice of mask interfaces. 31 We have previously reported differences in prescription practices among physicians of various specialties. 32 Physicians who specialized in the "parent" fields for sleep medicine-pulmonary medicine, neurology, and psychiatry-were less likely to prescribe sedatives to patients with as yet undiagnosed OSA. 32 Conversely, a survey by Chervin and colleagues appears to indicate that there is wide variability in practice patterns of physicians managing patients with sleep problems-regardless of their certification status. 33 In the present study, while prescription of medications for nasal congestion protected against discontinuing PAP therapy (OR 0.3, 95% CI 0.1-0.8; p = .02; Table 3 ), certified physicians were no more likely than noncertified physicians to prescribe medications for nasal congestion (p = .5; not shown). Therefore, such a mechanism is unlikely to be responsible for the effect of accreditation or certification status on discontinuation of PAP therapy.
We chose discontinuation of PAP therapy as the primary endpoint because, currently, it is unclear as to what threshold of hourly PAP-therapy use is acceptable and what, if any, are the benefits associated with an extra hour of nightly usage. 8 In keeping with this line of reasoning, we had originally powered the study based on continuation or discontinuation of PAP therapy and not hourly usage. Nevertheless, we did collect information regarding selfreported hourly PAP use, and the effects of accreditation or certification status on hour-based adherence to PAP therapy was no different than the effect of such status on discontinuation of PAP therapy. Moreover, while self-reporting of PAP-therapy usage is not as accurate as monitoring device compliance using microchip technology, 26 we do not believe that a systematic bias would have occurred across the patient groups compared in our study.
Nasal Congestion and Therapy
Previous studies have identified nasal congestion and symptoms as important reasons for abandoning PAP therapy or poor adherence. 7, 34 However, a systematic measurement of nasal symptoms using validated questionnaires in patients using PAP therapy has not been performed. Often, such nasal symptoms are attributed to PAP therapy. 35, 36 In our study, however, patients who had already discontinued PAP therapy reported higher nasal-congestion scores than did patients who were continuing to use their PAP devices. This would suggest that nasal congestion might play an important role in acceptance of PAP therapy, and, conceivably, such a role may be independent of the effect of PAP therapy on nasal symptoms. Additionally, the importance of nasal congestion on discontinuation of PAP therapy is further emphasized by our finding that prescription of medications for nasal congestion protected against discontinuation of PAP therapy (OR 0.3, 95% CI 0.1-0.8; p = .02; Table 3 ).
Satisfaction Rates
Certified physicians and accredited centers achieved greater satisfaction ratings from patients than did noncertified physicians and nonaccredited centers. Other factors determining patient satisfaction were receiving education leading to perception of health risks associated with OSA and outcome of treatment-whether they continued to use the PAP device or not and timeliness of care. This is consistent with other reports that have identified access to care and physician communication as important determinants of patient satisfaction. 37, 38 In light of this information, the sleep community and healthcare systems need to address the rising wait times (Figure) .
Wait Times
We chose the time lapse between first sleep study and delivery of PAP device because these are points in time that the patient is more likely to remember. Our data are consistent with recent reports of time delays for sleep evaluation in the United States, 10 but the magnitude of our wait times is lower than that reported by Flemons and colleagues. 10 Such a difference is probably due to the fact that the 2 studies measured different timeframes along the timeline of care delivered to patients with OSA. Our data, however, allow relating the wait times to patient satisfaction and also provide trends that allow extrapolation.
Limitations
There are several limitations to this study. First, this is an observational study, making it difficult to attribute cause-and-effect relationships. Second, self-selection of patients agreeing to participate in this study may not be representative of the average patient. Third, although response rate was good, it is unknown as to how the nonrespondents may have influenced the results. Fourth, this Internet-based survey does not include patients without Internet access and may have discounted patients belonging to lower socioeconomic strata or patients with disabilities. Fifth, race demographic was not sought, but we do not believe that this would have significantly affected the sampling because our patients' age, sex, height, and weight information are very similar to those in previous reports. Lastly, patients were asked to rely on their memory-especially with regard to time delays-and such information may be prone to recall bias.
